ERAS-4001 in combination Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Keytruda (pembrolizumab), Vectibix (panitumumab)

Filter by location:

Nashville, Tennessee1 trial

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

Sarah Cannon Research Institute (SCRI) Oncology Partners

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.